|
|
|
40
|
4145AB
|
NEVANAC 0.1% EYE DR (NVS/COL) NEPAFENAC
|
NEPAFENAC
|
NEVANAC
|
5ML
|
C
|
16.55
|
16.55
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520820
|
EENT NSAID
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
4145AB
|
NEVANAC 0.1% EYE DR (NVS) NEPAFENAC (C)
|
NEPAFENAC
|
NEVANAC
|
5ML
|
C
|
16.55
|
16.5546
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
3
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
4145AB
|
NEVANAC 0.1% EYE DR (NVS) NEPAFENAC
|
NEPAFENAC
|
NEVANAC
|
5ML
|
C
|
16.55
|
16.55
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
3
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
4145AE
|
NEPAFENAC 0.1% EYE DR (CIR/AHI)
|
NEPAFENAC
|
NEPAFENAC
|
5ML
|
A
|
7.48
|
7.48
|
EYE DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520820
|
EENT NSAID
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
3
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
4145AG
|
NEPATOP FREE 0.1% EYE DR (SYP) NEPAFENAC
|
NEPAFENAC
|
NEPATOP FREE
|
5ML
|
A
|
8.92
|
8.9161
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
3
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4145AG
|
NEPATOP FREE 0.1% EYE DR (SYP) NEPAFENAC
|
NEPAFENAC
|
NEPATOP FREE
|
5ML
|
A
|
9.11
|
9.11
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
3
|
EENT ANTI-INFLAMMATORY AGENTS
|
|